These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31881099)

  • 1. Metabolic syndrome, neurohumoral modulation, and pulmonary arterial hypertension.
    Maron BA; Leopold JA; Hemnes AR
    Br J Pharmacol; 2020 Apr; 177(7):1457-1471. PubMed ID: 31881099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure.
    Ameri P; Bertero E; Meliota G; Cheli M; Canepa M; Brunelli C; Balbi M
    Heart Fail Rev; 2016 Sep; 21(5):539-47. PubMed ID: 27206576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autonomic nervous system involvement in pulmonary arterial hypertension.
    Vaillancourt M; Chia P; Sarji S; Nguyen J; Hoftman N; Ruffenach G; Eghbali M; Mahajan A; Umar S
    Respir Res; 2017 Dec; 18(1):201. PubMed ID: 29202826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system.
    Liu C; Jiang XM; Zhang J; Li B; Li J; Xie DJ; Hu ZY
    BMC Cardiovasc Disord; 2016 Oct; 16(1):192. PubMed ID: 27724864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurohormonal modulation in pulmonary arterial hypertension.
    Peters EL; Bogaard HJ; Vonk Noordegraaf A; de Man FS
    Eur Respir J; 2021 Oct; 58(4):. PubMed ID: 33766951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone and Mineralocorticoid Receptor Antagonists on Pulmonary Hypertension and Right Ventricular Failure: A Review.
    Omidkhoda N; Vakilian F; Mohammadpour AH; Sathyapalan T; Sahebkar A
    Curr Pharm Des; 2020; 26(31):3862-3870. PubMed ID: 32445449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension.
    de Man FS; Tu L; Handoko ML; Rain S; Ruiter G; François C; Schalij I; Dorfmüller P; Simonneau G; Fadel E; Perros F; Boonstra A; Postmus PE; van der Velden J; Vonk-Noordegraaf A; Humbert M; Eddahibi S; Guignabert C
    Am J Respir Crit Care Med; 2012 Oct; 186(8):780-9. PubMed ID: 22859525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension.
    Nickel NP; Yuan K; Dorfmuller P; Provencher S; Lai YC; Bonnet S; Austin ED; Koch CD; Morris A; Perros F; Montani D; Zamanian RT; de Jesus Perez VA
    Am J Respir Crit Care Med; 2020 Jan; 201(2):148-157. PubMed ID: 31513751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting.
    Emanuel R; Chichra A; Patel N; Le Jemtel TH; Jaiswal A
    Ann Transl Med; 2018 Aug; 6(15):301. PubMed ID: 30211189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?
    de Man FS; Handoko ML; Guignabert C; Bogaard HJ; Vonk-Noordegraaf A
    Am J Respir Crit Care Med; 2013 Jan; 187(1):14-9. PubMed ID: 23144327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
    J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
    Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising therapeutic approaches in pulmonary arterial hypertension.
    Ali MK; Ichimura K; Spiekerkoetter E
    Curr Opin Pharmacol; 2021 Aug; 59():127-139. PubMed ID: 34217109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study.
    Maron BA; Opotowsky AR; Landzberg MJ; Loscalzo J; Waxman AB; Leopold JA
    Eur J Heart Fail; 2013 Mar; 15(3):277-83. PubMed ID: 23111998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for pulmonary arterial hypertension-associated right ventricular dysfunction.
    Gomez-Arroyo J; Sandoval J; Simon MA; Dominguez-Cano E; Voelkel NF; Bogaard HJ
    Ann Am Thorac Soc; 2014 Sep; 11(7):1101-15. PubMed ID: 25079379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series).
    Maron BA; Leopold JA
    Pulm Circ; 2014 Jun; 4(2):200-10. PubMed ID: 25006439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
    Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relevance of right ventricle in the clinical management of pulmonary arterial hypertension].
    Conde RE; Diez M; Dueñas R; Giacomi G; Lema L; Lescano A; Perna ER; Zayas Hernández N; Perrone SV;
    Medicina (B Aires); 2021; 81(4):624-636. PubMed ID: 34453806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the Metabolic Master Regulator PPARγ: A Potential PIOneering Therapy for Pulmonary Arterial Hypertension.
    Hansmann G; Calvier L; Risbano MG; Chan SY
    Am J Respir Cell Mol Biol; 2020 Feb; 62(2):143-156. PubMed ID: 31577451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Treatment Pathways in Pulmonary Arterial Hypertension.
    Qaiser KN; Tonelli AR
    Methodist Debakey Cardiovasc J; 2021; 17(2):106-114. PubMed ID: 34326930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.